Cancer Institute NSW Clinical Fellowship Program 2008

The Cancer Institute NSW Clinical Fellowship Program 2008 is designed to specifically address the need to provide a year of in-depth training and research for newly qualified specialists. The program aims to build upon and further support clinical cancer improvement, research and best practice.
In accordance with the Cancer Institute NSW Deed of Agreement, progress reports for 2008 Clinical Fellows must be submitted to the Cancer Institute NSW at the following intervals:

June 30 Progress report
December 31 Final Report

These reports enable to Cancer Institute NSW to assess whether satisfactory progress is being achieved. This report must be typed and submitted using this electronic form by the due date. A different reporting template will be provided for the final report at the conclusion of the fellowship program.

The Cancer Institute NSW is proud to announce the awarding of nine Cancer Institute NSW Clinical Fellowships for 2008, commencing in January. The Cancer Institute NSW would like to congratulate all nine recipients, their supervisors and administering institutions.

1.	Dr Christina Brown, Professor Harry Iland, (Supervisor) Institute of Haematology, Royal Prince Alfred Hospital, SSWAHS Research: MicroRNA expression in acute promyelocytic leukaemia.
2.	Dr Wei Chua; Professor Stephen Clarke, Dr Philip Beale, Associate Professor Mark Molloy and Dr Lisa Horvath (Supervisors) Medical Oncology, Concord Repatriation General Hospital, SSWAHS Research: Identification of Prognostic and Predictive Factors in Colorectal Cancer.
3.	Dr Julian Choi, Dr Thomas Hugh, Dr Jaswinder Samra and Professor Ross Smith (Supervisors) Upper GI Surgical Unit, Royal North Shore Hospital, NSCCAHS Research: Biomarkers in Pancreatic Cancer and Colorectal Liver Metastases.
4.	Dr Elisabeth Elder; Dr Katrina Moore, Professor Robert Baxter and Dr Andrew Spillane (Supervisors) Breast Oncology, Royal North Shore Hospital, NSCCAHS Research: The use of proteomics to identify proteins in serum which may predict node negative verses node positive breast cancer patients.
5.	Dr Farnoush Noushi; Associate Professor Andrew Spillane (Supervisor) Surgical Oncology - Mater Misericordiae Hospital, Royal North Shore Hospital Research: To comprehensively evaluate the role of internal mammary metastasis in breast cancer.
6.	Dr Peter O’Brien, Dr Jane Ludbrook and Dr Chris Wratten (Supervisors) Radiation Oncology, Calvary Mater Newcastle Hospital, HNEAHS Research: Validation of data interrogation capabilities of 3D review software (SWAN); development of generic 3D review protocols for use by medical reviewers for TROG trials; testing of the protocols; benchmarking of 3D protocols against international best practice; and developing workshops for training of medical reviewers in the use of 3D software.
7.	Dr Min Ru Qiu, Associate Professor Adrienne Morey, Professor Robert Sutherland and Dr Sandra Biankin (Supervisors) Anatomical Pathology, St Vincent’s Hospital, SESIHAS Research: To develop an Australian cohort of basal-like breast cancer and to characterize murine models of mammary carcinogenesis in order to facilitate our study of this clinically important "basal-like" breast cancer.
8.	Dr Nam Nguyen, Associate Professor Neil Merrett and Dr Rupert Leong (Supervisors) Surgical Oncology, Bankstown - Lidcombe Hospital, ,SSWAHS Research: To evaluate the role of tumour biomarkers in the management of pancreatic cancer, especially via the use of EUS guided FNA, and to investigate the impact of gastric electrical stimulation on gastric emptying and symptoms in patients who undergo pancreatodudenectomy.
9.	Professor John Forbes and Dr Stephen Ackland (Supervisors) Surgical Oncology, Calvary Mater Newcastle Hospital, HNEAHS Research: To participate in breast cancer clinical trials currently being conducted through the ANZ Breast Cancer Trials Group.